<SEC-DOCUMENT>0000950170-25-078346.txt : 20250528
<SEC-HEADER>0000950170-25-078346.hdr.sgml : 20250528
<ACCEPTANCE-DATETIME>20250528161619
ACCESSION NUMBER:		0000950170-25-078346
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250527
FILED AS OF DATE:		20250528
DATE AS OF CHANGE:		20250528

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Gao Hanlin
		CENTRAL INDEX KEY:			0001684532
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37894
		FILM NUMBER:		25995605

	MAIL ADDRESS:	
		STREET 1:		4399 SANTA ANITA AVE.
		CITY:			EL MONTE
		STATE:			CA
		ZIP:			91731

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fulgent Genetics, Inc.
		CENTRAL INDEX KEY:			0001674930
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				812621304
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		4399 SANTA ANITA AVE
		CITY:			EL MONTE
		STATE:			CA
		ZIP:			91731
		BUSINESS PHONE:		626-350-0537

	MAIL ADDRESS:	
		STREET 1:		4399 SANTA ANITA AVE
		CITY:			EL MONTE
		STATE:			CA
		ZIP:			91731

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Fulgent Diagnostics, Inc.
		DATE OF NAME CHANGE:	20160517
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2025-05-27</periodOfReport>

    <issuer>
        <issuerCik>0001674930</issuerCik>
        <issuerName>Fulgent Genetics, Inc.</issuerName>
        <issuerTradingSymbol>FLGT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001684532</rptOwnerCik>
            <rptOwnerName>Gao Hanlin</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O FULGENT GENETICS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>4399 SANTA ANITA AVENUE</rptOwnerStreet2>
            <rptOwnerCity>EL MONTE</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>91731</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>false</isDirector>
            <isOfficer>true</isOfficer>
            <isTenPercentOwner>false</isTenPercentOwner>
            <isOther>false</isOther>
            <officerTitle>Chief Scientific Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>false</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2025-05-27</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>false</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>383</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>20.5753</value>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>962691</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2025-05-27</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>false</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>656</value>
                    <footnoteId id="F3"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>20.5169</value>
                    <footnoteId id="F4"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>962035</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.</footnote>
        <footnote id="F2">The shares were sold in multiple transactions at prices ranging from $20.41 to $20.79, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.</footnote>
        <footnote id="F3">The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.</footnote>
        <footnote id="F4">The shares were sold in multiple transactions at prices ranging from $20.445 to $20.56, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Paul Kim as Attorney-in-Fact</signatureName>
        <signatureDate>2025-05-28</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
